Vanguard Mid-Cap Growth ETF
Stifel Downgrades Harley-Davidson to ‘Hold’
Harley-Davidson fell by 0.91% to close at $48.10 per share on July 15. Its weekly, monthly, and YTD price movements are -1.3%, 9.0%, and 7.8%, respectively.
BorgWarner Saw a Steep 9.5% Fall
BorgWarner (BWA) has a market cap of $7.6 billion. It fell by 9.5% to close at $33.84 per share on January 13, 2016.
Discussing Analysts’ Latest Recommendations on VAR Stock
Varian Medical Systems (VAR) is a better-aligned, leaner business with a strong market position after the spin-off of Varex Imaging (VREX) in January 2017.
Michael Kors’s Top Line and EPS Rose in 4Q16
Michael Kors’s (KORS) cash and cash equivalents fell by 28.3%, and its inventories rose by 5.2% in fiscal 2016.
Fairholme Lowers Its Stake in Leucadia National Corporation
Due to its long-term value-oriented investment style and its interests in diversified businesses, Leucadia National is known as Baby Berkshire.
Lululemon Athletica’s Revenue Rose, Income Fell in Fiscal 3Q15
Lululemon Athletica reported net revenue of $479.7 million for fiscal 3Q15, a rise of 14.4% when compared to net revenue of $419.4 million in fiscal 3Q14.
Lululemon Raised Projections and Seres Made Deal with Nestle
Lululemon Athletica (LULU) rose by 3.8% to close at $56.82 per share as of January 12, 2016.
Susquehanna Raises Price Target for Lululemon Athletica
Lululemon Athletica is trading 4.9% above its 20-day moving average, 11.7% above its 50-day moving average, and 2.4% below its 200-day moving average.
Why Barrington Research Cut Its Target Price on Dentsply Sirona
On March 27, 2018, Barrington Research reiterated its “buy” rating on Dentsply Sirona (XRAY) while reducing its target price on the stock from $70 to $69.
Wall Street Issues Majority ‘Buy’ Ratings on Align Technology
On December 29, 2017, according to 12 investment brokerage firms which were part of a Reuters survey, Align Technology stock has received a “buy” rating from 11 analysts.
Edwards Lifesciences Expands Portfolio with Harpoon Medical Acquisition
On December 6, 2017, Edwards Lifesciences (EW) announced the completion of its acquisition of Harpoon Medical for $100 million in cash on December 1, 2017.
Varian’s Latest Wall Street Recommendations: Mostly ‘Hold’
According to a recent Reuters survey, which included eight investment brokerage firms, six (or 75%) of them have recommended a “hold” for VAR stock.
Edwards Lifesciences: Analyst Recommendations in November
In 3Q17, Edwards Lifesciences (EW) reported adjusted sales of ~$838 million, which is an underlying growth of ~13% on a YoY basis. This performance was driven by double-digit organic growth.
Edwards Lifesciences: Analysts Expect 12.5% 3Q17 Revenue Growth
According to Wall Street analysts’ estimates for 3Q17, Edwards Lifesciences is expected to have revenues of $8.3 billion, a YoY (year-over-year) sales growth of 12.5%.
Developments in Dentsply Sirona’s Digital Dentistry Portfolio
On September 20, 2017, Dentsply Sirona (XRAY) announced an enhancement to its Galileos Implant software.
Jazz Pharmaceuticals on the Street: Analysts’ Recommendations after 1H17
In July 2017, Jazz Pharmaceuticals entered into a license agreement with XL-Protein GmbH involving products using XL-Protein’s PASylation technology.
FDA Approvals Could Drive Edwards Lifesciences’ Growth
On June 5, 2017, Edwards Lifesciences’ Sapien 3 valve was approved by the FDA for use in the aortic and mitral valve-in-valve procedure.
Discussing Dentsply Sirona’s Updated 2017 Guidance
Dentsply Sirona made a downward revision to its fiscal 2017 guidance during the company’s 2Q17 earnings results announcement on August 9, 2017.
Why Varian Medical Systems’ Profitability Is Improving
Varian Medical Systems’ profitability In 3Q17, Varian Medical Systems reported a gross margin of approximately 44.5%, representing an 18-basis-point improvement in the quarter. YTD (year-to-date), the margin has improved by around 138 basis points. In 3Q17, the company’s Oncology Systems business witnessed a gross margin improvement of 200 basis points to reach 48.1% of the segment’s total […]
Edwards Lifesciences Focuses on Launch of SAPIEN 3 Ultra and CENTERA Valves
Edwards Lifesciences’ (EW) SAPIEN 3 Ultra system is a next-generation platform, with expandable Axela sheath technology and on-balloon delivery design.
BioMarin Expects These Drugs to Generate Steady Revenues
In 2016, BioMarin Pharmaceuticals’ (BMRN) Naglazyme generated revenues of around $297 million, a ~2% year-over-year (or YoY) decline.
Baron: Under Armour Is Cheap Compared to the Last Couple of Years
Under Armour is currently struggling to meet investors’ expectations, as it missed analysts’ estimates in 4Q16. It reported a 12% rise in revenue in the quarter, missing expectations.
Piper Jaffray Downgrades Michael Kors Holdings to ‘Neutral’
On January 3, 2017, Piper Jaffray downgraded Michael Kors Holdings’s (KORS) rating from “overweight” to “neutral.” It also lowered the stock’s price target from $60.00 to $48.00 per share.
Morgan Stanley Downgrades Michael Kors Holdings to ‘Equal-Weight’
Michael Kors Holdings (KORS) has a market cap of $7.7 billion. It fell 5.1% to close at $47.16 per share on November 14, 2016.
A Look at Michael Kors Holdings’s Fiscal 2Q17 Performance
Michael Kors Holdings (KORS) has a market cap of $9.0 billion. It rose 3.2% to close at $51.76 per share on November 10, 2016.
Guggenheim Has Given Michael Kors Holdings a ‘Neutral’ Rating
Michael Kors Holdings (KORS) has a market cap of $7.9 billion. It fell 0.17% to close at $46.79 per share on September 30, 2016.
CLSA Rates Michael Kors Holdings as a ‘Sell’
Price movement Michael Kors Holdings (KORS) has a market cap of $7.9 billion. It fell 2.8% to close at $46.87 per share on September 29, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were -6.5%, -4.8%, and 17.0%, respectively, on the same day. KORS is trading 3.9% below its 20-day moving average, […]
Incyte’s Profitability Improves, Allowing for Revised Guidance
Incyte (INCY) reported revenues of $246.3 million in 2Q16, an increase of 51% compared to $163 million in 2Q15.
A Look at Michael Kors Holdings’s Performance in 1Q17
Michael Kors Holdings (KORS) has a market cap of $8.7 billion. It fell by 2.8% to close at $48.71 per share on August 10, 2016.
BorgWarner Declares Dividend of $0.13 Per Share
BorgWarner (BWA) has a market cap of $7.4 billion. It rose by 2.0% to close at $33.94 per share on July 26, 2016.
Why Are 430,000 Harley-Davidson Motorcycles Being Investigated?
Harley-Davidson (HOG) has a market cap of $8.9 billion. Its stock rose by 1.9% to close at $48.73 per share on July 8, 2016.
Why Did Harley-Davidson Rise ~20% on July 1?
Harley-Davidson (HOG) has a market capitalization of $8.2 billion. It rose by 19.8% to close at $54.25 per share on July 1, 2016.
Michael Kors Made Changes in Its Management
Michael Kors Holdings (KORS) is trading 9.9% above its 20-day moving average, 2.2% above its 50-day moving average, and 8.5% above its 200-day moving average.
Harman International Completed the Acquisition of TowerSec
Harman International Industries (HAR) has a market cap of $5.8 billion. It rose by 6.1%. It closed at $81.41 per share as of March 11, 2016.
Lululemon Startup Laid Off Staff to Focus on Branding
Lululemon Athletica (LULU) reported fiscal 3Q15 net revenue of $479.7 million, a rise of 14.4% when compared to net revenue of $419.4 million in fiscal 3Q14.
Harman’s Partnership with InterDigital to Expand its Business
Harman International Industries has entered into a partnership with InterDigital to deliver a suite of oneM2M- and 3GPP-compliant end-to-end Internet of Things (or IoT) solutions to the market.
Wells Fargo Upgraded Lululemon’s Rating to “Outperform”
After Wells Fargo upgraded its stock from “market perform” to “outperform,” Lululemon Athletica rose by 6.5% to close at $55.86 per share as of January 4.
How Did Lululemon Athletica Compare to Its Peers?
Lululemon Athletica (LULU) has mostly outperformed its peers, namely NIKE (NKE), The GAP Inc. (GPS), and Express Inc. (EXPR), based on PE, PBV, and PS.
Kraft Heinz’s US Segment Contributed 77% to Revenue
Kraft Heinz (KHC) operates in four segments—the US, Canada, Europe, and the Rest of World. The US segment’s net sales were $4.5 billion—a fall of 3.7%.
Hain Celestial’s Acquisitions in Fiscal 2015 and Their Benefits
In the third quarter of fiscal 2015, the Hain Celestial Group acquired the remaining ~80% of EK Holdings and its wholly owned subsidiary, Empire Kosher Poultry.
Kellogg’s Acquisitions and Their Benefits
The price of Kellogg’s acquisition of Diamond Foods is expected to reach over $1.5 billion, and Kellogg could offer the company between $35 and $40 per share.
VeriSign Adds 1.68 Million New Domain Names in 3Q15
In 3Q15, VeriSign (VRSN) had cash, cash equivalents, and marketable securities of $1.9 billion, an increase of $466 million compared to year-end 2014.
Eminence Capital Lowers Position in Autodesk
During the fourth quarter of 2014, Eminence Capital decreased its stake in Autodesk (ADSK). The company accounted for 2.62% of the fund’s 4Q14 portfolio.